Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.99
-0.07-1.72%
Last update: Jan 20, 9:28 AM
Comments
Loading...
Arbutus Biopharma (ABUS) Stock Price, Quote, News & History
ABUSNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Arbutus Biopharma (ABUS) stock?
You can purchase shares of Arbutus Biopharma (NASDAQ:ABUS) through any online brokerage.
Who are Arbutus Biopharma (ABUS) competitors?
Other companies in Arbutus Biopharma’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), KalVista Pharmaceuticals Inc (NASDAQ:KALV), Gyre Therapeutics Inc (NASDAQ:GYRE), Valneva SE (NASDAQ:VALN) and MapLight Therapeutics Inc (NASDAQ:MPLT).
What is the forecast, or price target, for Arbutus Biopharma (ABUS) stock?
Arbutus Biopharma has a consensus price target of $5.50.
What is the current price for Arbutus Biopharma (ABUS)?
The stock price for Arbutus Biopharma (NASDAQ: ABUS) is $3.99 last updated January 20, 2026 at 9:28 AM EST.
Does Arbutus Biopharma (ABUS) pay a dividend?
There are no upcoming dividends for Arbutus Biopharma.
When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?
Arbutus Biopharma does not have any upcoming earnings scheduled.
Is Arbutus Biopharma (ABUS) going to split?
There is no upcoming split for Arbutus Biopharma.
What sector and industry does Arbutus Biopharma (ABUS) operate in?
Arbutus Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
